Karyopharm grants 1,649 RSUs to four new hires under inducement plan
Share
Listen to the news
Karyopharm grants 1,649 RSUs to four new hires under inducement plan
  • Karyopharm Therapeutics granted 1,649 restricted stock units to four newly hired employees under its 2022 Inducement Stock Incentive Plan.
  • Awards were granted June 30, 2026.
  • RSUs vest over three years, with 33 1/3% vesting on each anniversary of the grant date, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607011605PR_NEWS_USPR_____NE94335) on July 01, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending